additional

Greenwich LifeSciences Provides Additional Updates on FLAMINGO-01 and Corporate Strategy

STAFFORD, Texas, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused…

2 weeks ago

Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze

December 19, 2025 18:10 ET  | Source: Vireo Growth Inc. MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc.…

2 weeks ago

Sequana Medical Announces Granting of Key Additional U.S. Patent for DSR

Ghent, Belgium, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Builds upon existing granted DSR patents in US, Europe, Japan and ChinaStrengthens…

3 weeks ago

BREAKWATER ENERGY HOLDINGS S. R.L. ANNOUNCES PRICING OF AN ADDITIONAL $75 MILLION OF ITS 9% SENIOR SECURED NOTES DUE 2030

LUXEMBOURG, Dec. 16, 2025 /PRNewswire/ -- Breakwater Energy Holdings S.à r.l. (the "Issuer") today announced that it has priced an…

3 weeks ago

India Deep Tech Alliance Announces Second Wave of Members, Additional 7,500 Crore ($850+ Million USD) Capital Commitments

Alliance expands roster of deep tech venture investors committed to making long‑term, thesis‑driven investments in Indian deep tech startups and…

2 months ago

ROCK & ROLL HALL OF FAME ANNOUNCES ADDITIONAL PRESENTERS AND PERFORMERS FOR 2025 INDUCTION CEREMONY

More Stars Join the Celebration of Music's Highest Honor, Streaming Live on Disney+ Saturday, Nov. 8 NEW YORK, Oct. 29,…

2 months ago

Cullinan Therapeutics Shares Additional Preclinical B Cell Depletion Data for CLN-978, Supporting Clinical Development Across Multiple Autoimmune Diseases, at ACR Convergence 2025

October 25, 2025 11:01 ET  | Source: Cullinan Therapeutics, Inc. CLN-978 led to rapid and deep B cell depletion in…

2 months ago

EquiLend’s 1Source Goes Live With BNY and National Bank of Canada. Additional Counterparties to Follow

A major step toward unified trade reconciliation across securities finance NEW YORK, Oct. 15, 2025 /PRNewswire/ -- EquiLend, the global…

3 months ago

Apogee Therapeutics, Inc. Announces Closing of Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares for Gross Proceeds of $345 Million

SAN FRANCISCO and BOSTON, Oct. 10, 2025 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company advancing…

3 months ago

Press Release: Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation

Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation The fund…

3 months ago